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INTRODUCTION
Fat grafting has become a widely used method for plastic sur-
geons and other surgical specialties in recent years [1]. Its appli-
cation in aesthetic, plastic and reconstructive surgery was re-
cently expanded by translational efforts involving adipose de-
rived progenitor cells and their use in regenerative medicine [2]. 
There is increasing evidence for fat grafts to play a vital role in 
novel therapeutic strategies [3]. Most current research is fo-
cused on mesenchymal stem cells, while the main clinical appli-
cations still consist of fat grafts that resemble adipocyte cluster 
transplants, without determination or purification of single cell 
types. For contouring effects, many surgeons prefer the method 
of Coleman [1] for harvesting and reinjecting.
Still, the fate of these transplanted fat grafts in vivo remains 
quite undefined. The determination of graft localization in a 
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transplantation target is difficult and cannot be simulated in vi-
tro. Our objective was to create a novel model for serial fat graft 
in vivo tracing, without the need to harvest the graft for further 
investigations. Quantum dots (QDs) were evaluated in this 
model as a labeling agent. QDs are small semiconductor nano-
crystals, with a size of usually < 10 nm [4]. QDs have the ability 
to emit fluorescence when excited with near infrared light. One 
of the major advantages lies in the wide absorption profile and 
an up to 10-fold greater molar extinction coefficient compared 
with organic dyes [4]. We have proven an intracellular uptake of 
QDs 675 in fat grafts before [5] and evaluated the use of the 
QDs as a new option for in vivo tracking in our current study.
METHODS
Experiments were performed according to the guiding princi-
ples for research involving animals and the German legislation 
on protection of animals. Approval was obtained with the local 
governmental animal care committee (No. 55.2-1-54-2531-53-
08).
BALB/c mice ( Janvier, Le Genest Saint Isle, France) were 
housed at the Department of Pharmaceutical Biology and Bio-
technology, Biotechnology and Nanomedicine, Ludwig Maxi-
milians University, Munich. Animals were allowed to accommo-
date to the standard conditions of the animal facility with free 
access to mouse chow and water.
Subcutaneous fat was surgically harvested under sterile condi-
tions from inguinal and abdominal region of BALB/c mouse, 
pooled and mechanically transected with scalpels. Collected fat 
grafts were diluted in 1 mL NaCl 0.9% on six well plates. There 
was no collagenase digestion or any other further processing of 
the harvested fat grafts, which were used immediately for incu-
bation and transplantation experiments. In this setting, determi-
nation of vitality was not realizable after harvesting. Fat grafts 
weight between 0.05 and 0.10 g.
Cadmium-telluride QDs (CdTe-QDs) were synthesized in 
water according to the previously published method [6]. The 
negatively charged CdTe-QDs 770 had a diameter of about 6.5 
nm and showed a characteristic near infrared excitation profile 
with a peak at 770 nm with an excitation wavelength of 740 nm 
[5]. 
Indocyanine green (Cardiogreen, Sigma-Aldrich, Munich, 
Germany) was used as a control tracing agent, because its ability 
to emit a fluorescence tracing signal, that can be compared in 
vivo to QDs in the same experimental setup.
There was no use of cell culture medium or fetal calf serum ad-
dition. For incubation experiments and short time storage saline 
solutions (NaCl 0.9%) were used. 
For in vivo experiments with fluorescence readings, BALB/c 
mice could be held under general isoflurane anesthesia with a 
custom-built small animal anesthesia unit in the IVIS Lumina 
Imaging System for the recurring scanning procedure (Caliper 
Life Science, Hopkinton, MA, USA) (Fig. 1). Near infrared ex-
citation was created by the IVIS Lumina Imaging System. Pho-
toluminescence as radiance was measured in photons/s/sr/cm2. 
Signal processing and imaging was performed with the Living 
Image Software 3.0 (Caliper Life Science). Received fluores-
cence signals were subtracted by software from the signal of the 
surrounding area and fused with the corresponding digital pho-
to that was created within the IVIS Lumina Imaging System.
To determine in vivo stability of the CdTe-QDs, 0.5 mL of a 9 
nmol/L CdTe-QDs solution was injected subcutaneously with-
out a fat graft in a caudocranial direction on the back of the ani-
mals under general isoflurane anaesthesia (n = 3). Also, indocya-
nine green (ICG) (0.5 mL of a 4 nmol/L solution) was injected 
in 0.5 mL aliquots as a control. Photoluminescence was scanned 
under general anesthesia on day 0, 1, 2, 3, 4, 5, 6, 10, 16, 23, and 
30. In addition, feces and urine were collected to document ex-
cretion of the labeling substances.
To evaluate a possible correlation of the fluorescence signal 
Fig. 1. Experimental setup for online detection 
IVIS Lumina Imaging System with custom-
built animal anesthesia unit for online fluo-
rescence readings in living small animals un-
der general anesthesia.
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with the vitality of the fat grafts, non-vital grafts were used as 
control group in addition to vital fat grafts for in vivo tracking. 
To create non-vital grafts as control groups, fat grafts under-
went heat-treatment with 80°C for 45 minutes. Afterwards the 
grafts were cooled down to 37°C and incubation procedures 
were started. This protocol was necessary, because QDs showed 
strong adhesion artifacts when confronted with higher tempera-
tures ( > 50°C), as well as with other chemicals, like alcoholic 
derivatives and other chemicals that are frequently used for in-
duction of cell death (data not shown). 
For incubation experiments, harvested vital and non-vital fat 
grafts were incubated with 9 nmol/L CdTe-QDs and rinsed 
with NaCl 0.9% twice. After the washing procedure, the fat 
grafts were filled into 2 mL syringes and injected into the back 
of BALB/c mice under general anesthesia with isoflurane and 
analgesia with carprofen (n = 3). Prior to injection experiments, 
the target area was shaved to avoid a reduction of photolumines-
cence. For injection a Strauss cannula, 15 gauge (1.8 × 43.0 mm) 
(Dispomed Witt oHG, Gelnhausen, Germany) was used. The 
puncture site was sealed with 2-octyl cyanoacrylate (Derma-
bond, Ethicon Inc., Norderstedt, Germany). Every Mouse was 
scanned serially daily for the first 7days and on day 10, 16, 23, 
30, 37, 43, and 50 in vivo. 
RESULTS
Stability of CdTe-QDs in vivo
To examine physical stability, injected CdTe-QDs (without fat 
grafts) were followed in vivo, as described above. ICG was in-
jected as a control substance. 
Photoluminescence results are shown in Fig. 2. The QD 770 
luminescence signal was on average reduced to 53.7% after 16 
days and showed a steady decline after 4 days. ICG was on aver-
age reduced to 41.8% after 24 hours and 16.7% after 3 days. ICG 
showed a sharp drop until the second day and then was reduced 
slowly. After 30 days, a remaining luminescence of 22.6% ±  
16.5% was found for the injected QD 770 and 5.7% ± 2.4% for 
the injected ICG.
In the ICG group, fluorescent tracer was found after 24 hours 
in the feces, documenting the known biliary excretion of ICG 
(data not shown). There was no measurable fluorescence in the 
ICG group urine, or in the QD 770 excrements.
Fig. 3. In vivo detection of transplanted fat clusters
In vivo fluorescence tracing of transplanted 
fat clusters with cadmium-telluride quantum 
dots (CdTe-QDs) 770. The fluorescence read-
ing was fused online with a picture of the 
target area.
Fig. 2. Course of QDs injection without fat graft
Photoluminescence time course of dorsally injected cadmium-tel-
luride quantum dots (CdTe-QDs) 770 and indocyanine green (ICG) 
as control in mice. Data are normalized to the initial fluorescent 
values and represent (mean±SD, n=3).
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Fat graft labeling with QD 770 in vivo
Vital and non-vital fat grafts were labeled with CdTe-QD 770 
and transplanted as described above. 
Fluorescence signal follow-up was received from the vital and 
non-vital fat grafts in vivo. After 30 days the signal was deterio-
rated in the fusion views, but still detectable (Fig. 3).
Absolute fluorescence values (Fig. 4) showed a detectable 
CdTe-QD 770 signal until the 50th day in the vital fat graft 
group. In the non-vital group all fat grafts were detected until 
day 43, whereas one graft was not detected on day 50 anymore. 
The average luminescence strength of the vital fat grafts was re-
duced more than 50% after 72 hours. Compared to the non-vital 
grafts, the initial signal was 5.96 times stronger. When looked at 
the relative fluorescence values to even out differences in the 
initial fluorescence levels (luminescence/luminescence on day 
0), we found a similar course on the first 5 days and afterwards 
an almost steady state in the non-vital graft group (Fig. 5).
After 30 days, the remaining fluorescent level was 4.9% ± 2.5% 
of the initial fluorescent level in the vital fat grafts and 24.3% ±  
16.4% in the non-vital fat grafts. The non-vital fat grafts showed 
comparable absolute levels of photoluminescence as the vital fat 
grafts (Fig. 5) at this time point. At day 50, the remaining lumi-
nescence levels were 4.2% ± 1.7% for the vital grafts and 6.3% ±  
5.6% with one graft not being detectable anymore from the 
non-vital fat grafts.
After 50 days, the tracing was terminated. Adipocyte clusters 
were surgically excised and openly examined under the IVIS 
Lumina System (Fig. 6). 
Fig. 4. Photoluminescence of vital and non-vital grafts
Fig. 5. Normalized photoluminescence of transplanted fat grafts
Absolute fluorescence values (mean±SD, n=3) of quantum dots (QDs) 770 incubated and subcutaneous transplanted fat clusters. The control 
group consisted of non-vital fat grafts (NV-FG) (n=3). 
Relative photoluminescence of quantum dots (QDs) 770 (mean±SD, n=3) incubated and subcutaneous transplanted fat clusters, compared to 
the initial value. NV-FG, non-vital fat grafts.
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As an incidental observation, transplanted vital fat grafts 
showed an increased revascularization at the end of the study 
(Fig. 6A), if compared to transplanted non-vital fat grafts. Fat 
grafts showed a remaining fluorescence signal ex vivo after 50 
days (Fig. 6B).
DISCUSSION
Fat cluster grafting has become a standard plastic surgical proce-
dure [1,7]. Unfortunately, there is not much experimental data 
supporting the clinical success of the frequently employed 
method [8]. Partly, the lacking data is caused by a scientific fo-
cus, which is currently put mainly on progenitor or stem cells, 
promising a broad functionality [9]. 
There have been few models for the follow-up of fat derived 
grafts using fluorescent dye. Rieck and Schlaak [10] used 
PKH26, a lipophilic dye for staining a collagenized fat derived 
cell suspension, which was injected subcutaneous, intramuscu-
larly and subcapsular into the kidney and was able to demon-
strate a fluorescent signal even after 6 months. The actual mea-
surement was done ex vivo in histological preparations under 
confocal microscopy. Also, Rieck and Schlaak [11] published a 
Lewis rat model for tracking of preadipocytes with PKH26 and 
demonstrated the examination ex vivo under confocal microsco-
py. Further substances for tracking of human preadipocytes 
were tested in vitro from Hemmrich et al. [12], stating a high 
toxicity for carboxyfluorescein succinimidyl ester (CFSE) and 
CM-DiI. CFSE, CM-DiI, and PKH 26 showed a remaining flu-
orescence of around 4% to 6% after 35 days in vitro. Zhou et al. 
[13] used luciferase transgenic rats and bioimaging to examine 
the difference between transplanted fat tissue with and without 
a stromal vascular fraction, showing a higher survival rate for the 
stromal vascular fraction group at 63 days. Furthermore Bliley 
et al. [14] used dioctadecyl-tetramethylindotricarbocyanine io-
dide, a near-infrared dye to track the stromal vascular fraction of 
fat grafts in vivo.
Our animal model clearly was inspired by the clinical use of 
micro fat grafts [15]. Since our model uses fat grafts in the form 
of micro fat cluster, there is a limitation of the scientific acuity 
concerning the determination of vitality, as well as cell count 
and origin. But on the other hand, fat alterations like collagenase 
digestion would have altered membrane proteins and cell viabil-
ity. We were willing to take this drawback in return for an animal 
model that reflects the clinical reality.
QDs were introduced as nanocrystals with unique lumines-
cent properties and stable fluorescence emission [4,16]. There 
has been a tremendous increase in the use of semiconductor 
QDs as a fluorescent label for imaging, tracing and sensing in 
living tissues [5,17,18]. There have been attempts to couple 
QDs to specific ligands for target specificity [17-19]. For our 
experiments, we used custom-built CdTe-QDs that were nega-
tively charged and had a diameter of 7 nm.
Yukawa et al. [20] described the use of CdSe/ZnS-core/shell 
nanocrystals as a potential labeling tool for adipose tissue-de-
Fig. 6. Examination of fat graft 
Fat cluster transplants were excised and examined 50 days after cluster labeling with cadmium-telluride quantum dots (CdTe-QD) 770: vital 
transplanted adipocyte clusters showed frequently increased revascularization (A). The graft result presents spherical, despite of a more areal 
transplantion of the fat graft, probably based on a pooling effect due to animal movement. There was a remaining direct fluorescence signal on 
the transplants, when examined ex vivo (B). Not all transplanted fat clusters showed an in vivo signal after 50 days.
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rived stem cells (ASCs). Also, a transfection with QDs of ASCs 
with a cell penetrating peptide was reported. The fluorescence 
intensity was maintained for at least 2 weeks with the used QDs 
655 [21].
To our knowledge, our experiment presented for the first time 
the tracking of fat grafts in a continuous in vivo model. The cho-
sen marker QD 770 showed the potential for a useful applicabil-
ity. 
The non-vital fat grafts, which were chosen as controls, 
showed a reduced absolute QDs uptake in our experiments, but 
we were not able to correlate a specific uptake to the viability of 
a fat graft. Therefore, the QDs labeling tool remains a tracking, 
rather than a viability tool, which is a limitation of the current 
experimental model. In vivo online tracking might play a role for 
follow-up of functional fat grafts for nerve cushioning, wound 
healing or other new indications, especially in an experimental 
setup. Other methods should be applied, if vitality of fat grafts is 
subject of an investigation.
Morphologically the fluorescent shape of the injected clusters 
became cohesive over time, although the fat transplantation was 
performed in a pearl array. This was already observed in other 
fat graft experiments and was earlier contributed to the move-
ment of the animals [22]. Also, this mechanism seems to be a 
potential contributor for an intercalated increase of fluorescence 
values per area in some groups over time.
The signals also showed no hint for in vivo leaking to the sur-
rounding of the labeling markers in the QD in the form of radial 
spreading, although leaking poses a potential problem that has 
to stay in the focus of further research.
QD 770 showed a sustaining labeling quality in form of a slow 
fading out of photoluminescence.
After 16 days in vivo tracing, there was on average 14.1% of the 
initial QDs fluorescence level. Therefore, QDs seem to permit 
tracing for medium to long-term tracking experiments. 
Toxicity of QDs is to date not finally evaluated. Since the core 
of QDs are usually based on heavy metals, like cadmium in the 
used CdTe-QDs, toxicity has to be addressed in further studies 
[4]. We did not observe acute toxicity on microscopic evalua-
tion. CdTe-QDs reportedly showed cytotoxic properties to a 
breast cancer cell line, which were not dose dependent to the in-
tracellular Cd2+levels [23]. Other groups observed no histolog-
ical changes with CdSe(0.25)Te(0.75)/CdS -QDs in major or-
gans, when administered in a mouse model, even at high doses 
[24]. The accumulation of nanoparticles in organs, like liver or 
spleen was recently described [25].
In vivo tracking of fat graft with QDs represents a new tool in 
the arsenal of applied nanotechnology, while further tests are 
necessary to exclude a potential toxicity. The application of this 
novel model for fat graft tracing could be useful in the evalua-
tion of new functional and aesthetical fat graft transplants.
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